Responsibility of a Pharmaceutical Company on Medicine Safety (Case Study on Paracetamol Syrup)
Abstract
Cases of medicine poisoning derived from paracetamol syrup that is currently rampant have caused acute kidney failure in children. This is known because of the content of harmful substances contained in the medicine. The dangerous substances contained in the medicine are Ethylene Glycol and Diethylene Glycol. Paracetamol syrup poisoning cases have claimed many victims. Up to now, 269 victims have experienced acute kidney failure and 157 of them are declared dead. This article analyses the responsibility of pharmaceutical companies in securing medicine in cases that occur and how legal steps are to protect the interests of victims and their families. The research methods employed normative legal methods sourced from secondary data in the form of legal materials and non-legal materials. The qualitative approach is descriptive and the data collection is qualitative. Qualitative data analysis using the Miles and Huberman model where the narrative and secondary data are examined with analysis content. This case is caused by intentional or negligence on the part of the pharmaceutical company producing the medicine in the production process and carelessness in the packaging and distribution of these medicines. The Ministry of Health and the Food and medicine Supervisory Agency (BPOM) are also recognized for being careless in supervising and issuing proper distribution permits for these medicines. There must be a responsibility from the parties concerned to the victims and their…
Read the paper
Related studies
- Effect of dexamethasone as an analgesic adjuvant to multimodal pain treatment after total knee arthroplasty: randomised clinical trial
- Effect of a Postoperative Multimodal Opioid-Sparing Protocol vs Standard Opioid Prescribing on Postoperative Opioid Consumption After Knee or Shoulder Arthroscopy: A Randomized Clinical Trial
- Comparison of the Post-Caesarean Analgesic Effect of Adding Dexmedetomidine to Paracetamol and Ketorolac: A Randomized Clinical Trial
- A triple-blind randomized clinical trial of different associations between dexamethasone and non-steroids anti-inflammatories for preemptive action in third molar extractions
- An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients
- Oral paracetamol and/or ibuprofen for treating pain after soft tissue injuries: Single centre double-blind, randomised controlled clinical trial
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.